首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1683666

全球体外诊断市场研究报告-产业分析、规模、份额、成长、趋势与预测 2025 年至 2033 年

Global In Vitro Diagnostics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年03月01日 | 出版商:

Value Market Research | 英文 252 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球体外诊断市场规模预计将从 2024 年的 896.4 亿美元成长到 2033 年的 1,261.6 亿美元，在 2026 年至 2033 年的预测期内呈现 3.87% 的强劲年复合成长率(CAGR)。

随着慢性病发病率不断上升以及对早期准确诊断解决方案的需求不断增长，体外诊断（IVD）市场有望大幅成长。 IVD 测试是对血液、尿液和组织等样本进行的，在疾病检测、监测和管理中发挥关键作用。随着医疗保健提供者越来越重视个人化医疗和预防保健，对先进 IVD 技术的需求预计将上升。分子诊断、即时诊断和自动化方面的创新正在提高诊断过程的准确性和效率，进一步推动市场成长。

IVD技术的进步也正在塑造这个市场的未来。快速测试方法的发展以及人工智慧和机器学习在资料分析中的整合正在彻底改变诊断的方式。这些创新使医疗保健专业人员能够及时获得结果，促进更快地做出决策并改善患者的治疗效果。此外，由于患者寻求方便、易于获得的诊断解决方案，家庭检测和远距医疗的成长趋势可能会对 IVD 市场产生正面影响。

此外，新兴经济体医疗保健基础设施的扩张预计将对体外诊断市场产生积极影响。随着亚太、拉丁美洲等地区医疗保健条件的改善和对优质诊断服务的需求增加，IVD产品的消费量将会上升。专注于开发满足特定区域需求的创新且具有成本效益的诊断解决方案的公司将占据有利地位以占领市场份额。随着 IVD 市场的发展，技术进步、监管变化和消费者偏好转变的相互作用将创造一个充满成长和创新机会的动态环境。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业趋势
波特五力分析
市场吸引力分析
- 市场吸引力分析：按产品类型
- 依技术进行市场吸引力分析
- 市场吸引力分析：按应用
- 最终用户的市场吸引力分析
- 市场吸引力分析：按地区

第四章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料製造商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球体外诊断市场分析：依产品类型

概览：依产品类型
历史与预测资料分析：按产品类型
仪器
试剂
软体
服务

第 6 章：全球体外诊断市场分析：按技术

技术概览
按技术进行的历史和预测数据分析
免疫分析
临床化学
分子诊断
血液学
微生物学
凝血
其他的

第 7 章：全球体外诊断市场分析：按应用

概述：按应用
历史和预测数据分析：按应用
传染病
肿瘤学
心臟病学
肾臟病学
自体免疫疾病
其他的

第 8 章：全球体外诊断市场分析：依最终用户

最终用户概览
最终用户的历史和预测数据分析
医院
诊断实验室
学术及研究机构
其他的

第 9 章：全球体外诊断市场分析：按地区划分

区域展望
介绍
北美销售分析
- 概述、历史和预测数据销售分析
- 北美各细分市场销售分析
- 北美各国销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概述、历史和预测数据销售分析
- 欧洲各细分市场销售分析
- 欧洲各国销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概述、历史和预测数据销售分析
- 亚太地区分部销售分析
- 亚太地区国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概述、历史和预测数据销售分析
- 拉丁美洲各细分市场销售分析
- 拉丁美洲各国销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概述、历史和预测数据销售分析
- 中东和非洲分部销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东和非洲其他地区销售分析

第 10 章：体外诊断公司的竞争格局

体外诊断市场竞争
伙伴关係/合作/协议
合併与收购
新产品发布
其他进展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
Roche Diagnostics

公司概况
公司收入
产品
最新动态

Abbott Laboratories

公司概况
公司收入
产品
最新动态

Siemens Healthineers

公司概况
公司收入
产品
最新动态

Danaher Corporation

公司概况
公司收入
产品
最新动态

Thermo Fisher Scientific

公司概况
公司收入
产品
最新动态

Becton

公司概况
公司收入
产品
最新动态

Dickinson And Company (BD)

公司概况
公司收入
产品
最新动态

Bio-Rad Laboratories

公司概况
公司收入
产品
最新动态

BioMAfA(C)Rieux

公司概况
公司收入
产品
最新动态

Qiagen

公司概况
公司收入
产品
最新动态

Hologic

公司概况
公司收入
产品
最新动态

Sysmex Corporation

公司概况
公司收入
产品
最新动态

Ortho Clinical Diagnostics

公司概况
公司收入
产品
最新动态

Agilent Technologies

公司概况
公司收入
产品
最新动态

Illumina"

公司概况
公司收入
产品
最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

简介目录图表

Product Code: VMR11218520

Global In Vitro Diagnostics Market size is anticipated to grow from USD 89.64 Billion in 2024 to USD 126.16 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 3.87% during the forecast period of 2026 to 2033.

The in vitro diagnostics (IVD) market is poised for substantial growth, driven by the increasing prevalence of chronic diseases and the rising demand for early and accurate diagnostic solutions. IVD tests, which are performed on samples such as blood, urine, and tissue, play a critical role in disease detection, monitoring, and management. As healthcare providers increasingly prioritize personalized medicine and preventive care, the demand for advanced IVD technologies is expected to rise. Innovations in molecular diagnostics, point-of-care testing, and automation are enhancing the accuracy and efficiency of diagnostic processes, further propelling market growth.

Technological advancements in IVD are also shaping the future of this market. The development of rapid testing methods and the integration of artificial intelligence and machine learning in data analysis are revolutionizing the way diagnostics are performed. These innovations enable healthcare professionals to obtain timely results, facilitating quicker decision-making and improved patient outcomes. Additionally, the growing trend towards home-based testing and telemedicine is likely to influence the IVD market positively, as patients seek convenient and accessible diagnostic solutions.

Moreover, the expansion of healthcare infrastructure in emerging economies is expected to positively impact the in vitro diagnostics market. As access to healthcare improves and the demand for quality diagnostic services increases in regions such as Asia-Pacific and Latin America, the consumption of IVD products will rise. Companies that focus on developing innovative and cost-effective diagnostic solutions tailored to specific regional needs will be well-positioned to capture market share. As the IVD market evolves, the interplay of technological advancements, regulatory changes, and shifting consumer preferences will create a dynamic environment ripe with opportunities for growth and innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

Instruments
Reagents
Software
Services

By Technology

Immunoassay
Clinical Chemistry
Molecular Diagnostics
Hematology
Microbiology
Coagulation
Others

By Application

Infectious Diseases
Oncology
Cardiology
Nephrology
Autoimmune Diseases
Others

By End-User

Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Others
COMPANIES PROFILED
Roche Diagnostics
Abbott Laboratories
Siemens Healthineers
Danaher Corporation
Thermo Fisher Scientific
Becton
Dickinson and Company (BD)
Bio-Rad Laboratories
bioMA(C)rieux
Qiagen
Hologic
Sysmex Corporation
Ortho Clinical Diagnostics
Agilent Technologies
Illumina"
The above list can be customized.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. IN VITRO DIAGNOSTICS INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-User
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Instruments Historic and Forecast Sales By Regions
5.4. Reagents Historic and Forecast Sales By Regions
5.5. Software Historic and Forecast Sales By Regions
5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data Analysis By Technology
6.3. Immunoassay Historic and Forecast Sales By Regions
6.4. Clinical Chemistry Historic and Forecast Sales By Regions
6.5. Molecular Diagnostics Historic and Forecast Sales By Regions
6.6. Hematology Historic and Forecast Sales By Regions
6.7. Microbiology Historic and Forecast Sales By Regions
6.8. Coagulation Historic and Forecast Sales By Regions
6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data Analysis By Application
7.3. Infectious Diseases Historic and Forecast Sales By Regions
7.4. Oncology Historic and Forecast Sales By Regions
7.5. Cardiology Historic and Forecast Sales By Regions
7.6. Nephrology Historic and Forecast Sales By Regions
7.7. Autoimmune Diseases Historic and Forecast Sales By Regions
7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY END-USER

8.1. Overview By End-User
8.2. Historical and Forecast Data Analysis By End-User
8.3. Hospitals Historic and Forecast Sales By Regions
8.4. Diagnostic Laboratories Historic and Forecast Sales By Regions
8.5. Academic and Research Institutes Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL IN VITRO DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE IN VITRO DIAGNOSTICS COMPANIES

10.1. In Vitro Diagnostics Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF IN VITRO DIAGNOSTICS INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Roche Diagnostics
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Abbott Laboratories
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Siemens Healthineers
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Danaher Corporation
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Thermo Fisher Scientific
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Becton
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Dickinson And Company (BD)
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Bio-Rad Laboratories
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. BioMAfA(C)Rieux
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Qiagen
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Hologic
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Sysmex Corporation
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
11.15. Ortho Clinical Diagnostics
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments
11.16. Agilent Technologies
- 11.16.1 Company Overview
- 11.16.2 Company Revenue
- 11.16.3 Products
- 11.16.4 Recent Developments
11.17. Illumina"
- 11.17.1 Company Overview
- 11.17.2 Company Revenue
- 11.17.3 Products
- 11.17.4 Recent Developments